We reportsignificant downregulation of genes that are underrepresented within theliterature, such as ADH7, GCNT2, andLIF1, while other genes have not been explored withingastric cancer to the best of our knowledge such as METTL7A,MAL, CWD43, and SLC2A12.We identified gender to be another heterogeneous component of this disease andsuggested targeted treatment strategies specific to this heterogeneity. This evidence concerns the gene GCNT2 and cancer.